Transepithelial Barrier Dysfunction Drives Microbiota Dysbiosis to Initiate Epithelial Clock-driven Inflammation
Journal of Crohn's and Colitis · 20.10.2023 · 17 (9) · 1471-1488
DOI: 10.1093/ecco-jcc/jjad064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 02.04.2023. Verfasst von Yu-Chen Pai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Physiology, National Taiwan University College of Medicine, Taipei, Taiwan ROC. Hauptthemen laut MEDLINE: Dysbiosis, Intestinal Mucosa, Myosin-Light-Chain Kinase, Gastrointestinal Microbiome. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Background
Factors that contribute to inflammatory bowel disease [IBD] pathogenesis include genetic polymorphisms, barrier loss, and microbial dysbiosis. A major knowledge gap exists in the origins of the colitogenic microbiome and its relationship with barrier impairment. Epithelial myosin light chain kinase [MLCK] is a critical regulator of the paracellular barrier, but the effects of MLCK activation on the intraepithelial bacteria [IEB] and dysbiosis are incompletely understood. We hypothesise that MLCK-dependent bacterial endocytosis promotes pathobiont conversion and shapes a colitogenic microbiome.
Methods
To explore this, transgenic [Tg] mice with barrier loss induced by intestinal epithelium-specific expression of a constitutively active MLCK were compared with wild-type [WT] mice.
Results
When progeny of homozygous MLCK-Tg mice were separated after weaning by genotype [Tg/Tg, Tg/WT, WT/WT], increased IEB numbers associated with dysbiosis and more severe colitis were present in Tg/Tg and Tg/WT mice, relative to WT/WT mice. Cohousing with MLCK-Tg mice induced dysbiosis, increased IEB abundance, and exacerbated colitis in WT mice. Conversely, MLCK-Tg mice colonised with WT microbiota at birth displayed increased Escherichia abundance and greater colitis severity by 6 weeks of age. Microarray analysis revealed circadian rhythm disruption in WT mice co-housed with MLCK-Tg mice relative to WT mice housed only with WT mice. This circadian disruption required Rac1/STAT3-dependent microbial invasion but not MLCK activity, and resulted in increased proinflammatory cytokines and glucocorticoid downregulation.
Conclusions
The data demonstrate that barrier dysfunction induces dysbiosis and expansion of invasive microbes that lead to circadian disruption and mucosal inflammation. These results suggest that barrier-protective or bacterium-targeted precision medicine approaches may be of benefit to IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Physiology, National Taiwan University College of Medicine, Taipei, Taiwan ROC.
- Brigham's Women Hospital, Harvard Medical School, Boston, MA, USA.
Förderung
- NIDDK NIH HHS
- NIH HHS
- Ministry of Science and Technology, Taiwan
- National Health Research Institutes
- National Taiwan University
- National Institutes of Health
Zitieren
APA
Pai, Y. C., Li, Y. H., Turner, J. R., & Yu, L. C. (2023). Transepithelial Barrier Dysfunction Drives Microbiota Dysbiosis to Initiate Epithelial Clock-driven Inflammation. Journal of Crohn's and Colitis, 17(9), 1471-1488. https://doi.org/10.1093/ecco-jcc/jjad064
Vancouver
Pai YC, Li YH, Turner JR, Yu LC. Transepithelial Barrier Dysfunction Drives Microbiota Dysbiosis to Initiate Epithelial Clock-driven Inflammation. Journal of Crohn's and Colitis. 2023;17(9):1471-1488. doi:10.1093/ecco-jcc/jjad064
BibTeX
@article{Pai2023,
author = {Pai, Yu-Chen and Li, Yi-Hsuan and Turner, Jerrold R and Yu, Linda Chia-Hui},
title = {Transepithelial Barrier Dysfunction Drives Microbiota Dysbiosis to Initiate Epithelial Clock-driven Inflammation},
journal = {Journal of Crohn's and Colitis},
year = {2023},
volume = {17},
number = {9},
pages = {1471--1488},
doi = {10.1093/ecco-jcc/jjad064}
}
EUVIMED